DEARBORN PARTNERS LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1206792 Chicago, IL

Position in NTLA

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$267,758

+$75,536 QoQ

Shares Held

15,825

+5.5% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#193

of 327 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 32% Shared 0% None 68%

Healthcare · as of Jun 30, 2026

DEARBORN PARTNERS LLC holds $630,532 across 3 Biotechnology names. NTLA ranks #2 (42.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	1,300	$346,736
2	NTLA	Intellia Therapeutics, Inc. This page	15,825	$267,758
3	IGC	IGC Pharma, Inc.	59,401	$16,038

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$267,758	15,825	+5.5%	Shares	Sole	2026-08-17
2026-03-31	$192,222	14,994	-14.1%	Shares	Sole	2026-05-12
2025-12-31	$156,910	17,454	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.